Helicobacter pylori (HP) type and drug-resistant mutation gene detection kit
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 杭州千基生物科技有限公司
- Publication Date
- 2015-08-19
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a gene detection kit, in particular to a Helicobacter pylori typing and drug resistance mutation gene detection kit. Background technique
[0002] Helicobacter Pylori (HP) was first isolated from the gastric mucosa of gastritis patients in 1983 by Barry J. Marshall and J. Robin Warren. Studies have shown that inflammation caused by HP can lead to atrophic gastritis, intestinal metaplasia, dysplasia, and eventually gastric adenocarcinoma.
[0003] The whole gene sequence of HP has been determined, and the urease gene has four open reading frames, which are UreA, UreB, UreC and UreD. The polypeptides encoded by UreA and UreB are structurally equivalent to the two subunits of the urease structure. The urease of Helicobacter pylori is extremely rich, containing about 15% of bacterial protein, and its activity is 400 times that of Proteus. Urease catalyzes the hydrolysis of urea to form an "ammonia cloud" to protect bacteria from...